Indiana lawmakers are weighing new guardrails around drug compounding amid warnings that patients are receiving powerful prescription treatments in settings that operate largely outside state ...
The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...
Hims & Hers Health, Inc. faces volatile earnings as compounded GLP-1 setbacks pressure shares. Click for this HIMS stock ...
Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.
This article was reviewed by Darragh O’Carroll, MD. Key Takeaways: GLP-1s are used for type 2 diabetes, as well as weight loss in people with obesity ...
The arrest occured one day after an undercover investigation foiled a drug smuggling attempt along the Jordanian border.
Hims & Hers Health (NYSE:HIMS) launched a compounded semaglutide weight loss pill, then quickly discontinued it after a patent infringement lawsuit from Novo Nordisk. The company is under increased ...
Opinion
11hon MSNOpinion
FDA's Marty Makary: Everything should be over-the-counter unless it's unsafe or requires monitoring
FDA's Marty Makary sits down with CNBC's Annika Kim Constantino to discuss the vaccine regulatory environment, compounding GLP-1 drugs and his efforts to change a large swath of prescription drugs to ...
There has been increased interest in over-the-counter GLP-1 patches. If you’re thinking about using, here’s what you should know.
Wholly-owned laboratory has received CLIA certification from Massachusetts with full license to conduct patient testing and develop companion diagnostics ...
The grandson of the inventor of Reese’s Peanut Butter Cups is lashing out at The Hershey Co., accusing the candy company of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results